Question 1

What is CBIO's dilution risk score?

Accepted Answer

CBIO currently has a DilutionScore of 45/100, indicating medium dilution risk. DilutionWatch monitors CBIO SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

Question 2

What SEC filings does DilutionWatch track for CBIO?

Accepted Answer

DilutionWatch tracks 25 SEC filing types for CBIO including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

Question 3

How does stock dilution affect CBIO shareholders?

Accepted Answer

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CBIO, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Question 4

Is DilutionWatch free for CBIO tracking?

Accepted Answer

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CBIO. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CBIO — Crescent Biopharma, Inc. Dilution Risk Tracker

📊 Score Breakdown

🌦️ Dilution Forecast

💹 Market Data

🏛 Institutional Holdings

📉 Short Interest

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

📰 Recent News